ASMB ▲ +1.1% - Assembly Biosciences, Inc. $ASMB - Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026 05-OCT-2026 10:00 AM ET